CDH1 and breast carcinoma: We used a four-marker panel to define the EMT phenotypes and found a similar distribution as reported previously in a large study classifying EMT phenotypes based upon the expression pattern of E-cadherin and fibronectin in PT samples from 1495 breast cancer patients [16].